drugset / Trial / NCT02460341

The Effects of Ondansetron on Brain Function

NCT02460341

Phase 1 Completed 54 enrolled Icahn School of Medicine at Mount Sinai
RandomizedCrossoverDouble-blindBasic science

Summary

This project investigates the effects of a single dose of ondansetron on brain function in healthy adults. The investigators hypothesize that there will be a dose-dependent reduction in activation of the insula and somatosensory brain regions associated with the use of ondansetron.

Timeline

Start
2015-08
Primary completion
2017-02-03
Completion
2017-02-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 8 mg
Subject Ondansetron Other / unclassified 16 mg
Subject Ondansetron Other / unclassified 24 mg

Indications

No indication recorded.